On Monday shares of Regions Financial Corporation (NYSE:RF) closed at $10.21. Company’s sales growth for last 5 years was -7.40% and EPS growth for next 5 years is recorded as 6.03%. Sandler O’Neill reaffirmed their buy rating on shares ofRead More
On Monday shares of Lakeland Industries Inc. (NASDAQ:LAKE) closed at $10.47. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Lakeland Industries, Inc. (NASDAQ: LAKE), announcedRead More
On Monday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $14.20. Sorrento Therapeutics (NASDAQ:SRNE)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainright in a research report issued on Friday. They currently have a $20.00 target priceRead More
On Monday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $3.34. May 15, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare ConferenceRead More
On Monday shares of OXiGENE, Inc. (NASDAQ:OXGN) closed at $1.39. On May 12, OXiGENE, Inc. (NASDAQ:OXGN) announced the appointment of a new President and Chief Executive Officer, Bill Schwieterman, M.D. The company’s current CEO, Dai Chaplin, Ph.D., will become ChiefRead More
On Monday shares of Athersys, Inc. (NASDAQ:ATHX) closed at $1.33. Company’s sales growth for last 5 years was -6.20% and EPS growth for next 5 years is recorded as 28.00%. Athersys Inc. (NASDAQ:ATHX) on May 11 reported a loss ofRead More
On Monday shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) closed at $20.27. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced the commencement of a proposed underwritten public offering of 2,750,000 shares of common stock. Dicerna also intends to grant the underwriters a 30-day optionRead More
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) in last trading activity advanced 3.84% to close at $20.27. Company weekly performance is -10.51% while its quarterly performance stands at -5.98%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) is -25.83% away from its 52 week high. Dicerna Pharmaceuticals,Read More
On Monday shares of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) closed at $0.63. Company’s sales growth for last 5 years was -41.20%. On May 14, NovaBay® Pharmaceuticals, Inc. (NYSEMKT:NBY), reported financial results for the three months ended March 31, 2015, and providedRead More
On Monday shares of Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) closed at $1.15. Company’s sales growth for last 5 years was 2.90%. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) announced its operating results for the first quarter of 2015.The Company reported top line sales ofRead More
Renewable Energy Systems Power Long-Term Growth Potential for Global Battery Demand 
Michael Baker International Names Gil Bosque, P.E., Vice President and Hamilton, New Jersey, Office Executive 
CleanSpark Announces Two New EV Contracts for GridFabric Software Subscriptions 
Biden’s Vacillating on Fracking Could Put America at Risk, said Energy Industry Leader Fred Schneiderman at 20 Days to Save the USA